drugset / Trial / NCT05964101
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open, II phase study to evaluate the safety and efficacy of Nivolumab + carboplatin + paclitaxel in 25 newly diagnosed patients with primary tracheal squamous cell carcinoma.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2025-08-01
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | — |
| Subject | Nivolumab | Monoclonal antibody | 360 mg | — |
| Subject | Paclitaxel | Small molecule | 100 mg/m2 | — |